PFBT
LLY icon

Parkside Financial Bank & Trust’s Eli Lilly LLY Stock Holding History

Parkside Financial Bank & Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.13M Buy
7,749
+8
+0.1% +$8.11K 0.55% 32
2025
Q4 		$8.32M Sell
7,741
-28
-0.4% -$26.8K 0.62% 27
2025
Q3 		$5.93M Sell
7,769
-84
-1% -$62.5K 0.46% 37
2025
Q2 		$6.12M Buy
7,853
+1,249
+19% +$971K 0.66% 30
2025
Q1 		$5.45M Buy
6,604
+156
+2% +$130K 0.69% 26
2024
Q4 		$4.98M Buy
6,448
+56
+0.9% +$46.4K 0.66% 27
2024
Q3 		$5.66M Buy
6,392
+22
+0.3% +$19.8K 0.79% 22
2024
Q2 		$5.77M Buy
6,370
+75
+1% +$60K 0.9% 22
2024
Q1 		$4.9M Buy
6,295
+1,397
+29% +$994K 0.79% 23
2023
Q4 		$2.86M Buy
4,898
+2,370
+94% +$1.38M 0.52% 39
2023
Q3 		$1.36M Buy
2,528
+244
+11% +$126K 0.31% 60
2023
Q2 		$1.07M Buy
2,284
+56
+3% +$23.5K 0.25% 68
2023
Q1 		$765K Sell
2,228
-4
-0.2% -$1.35K 0.21% 85
2022
Q4 		$817K Buy
2,232
+75
+3% +$26.6K 0.24% 75
2022
Q3 		$697K Sell
2,157
-411
-16% -$130K 0.22% 72
2022
Q2 		$833K Buy
2,568
+101
+4% +$30.3K 0.25% 67
2022
Q1 		$707K Buy
2,467
+235
+11% +$60.5K 0.19% 83
2021
Q4 		$616K Sell
2,232
-54
-2% -$13.7K 0.15% 110
2021
Q3 		$528K Buy
2,286
+42
+2% +$10.4K 0.16% 100
2021
Q2 		$515K Buy
2,244
+70
+3% +$14.1K 0.15% 101
2021
Q1 		$406K Sell
2,174
-181
-8% -$35.4K 0.12% 125
2020
Q4 		$398K Buy
2,355
+231
+11% +$34.5K 0.12% 121
2020
Q3 		$314K Sell
2,124
-945
-31% -$146K 0.11% 126
2020
Q2 		$504K Buy
3,069
+44
+1% +$6.75K 0.16% 93
2020
Q1 		$420K Buy
3,025
+18
+0.6% +$2.47K 0.16% 89
2019
Q4 		$395K Sell
3,007
-575
-16% -$66.7K 0.12% 129
2019
Q3 		$401K Sell
3,582
-295
-8% -$32.8K 0.13% 120
2019
Q2 		$430K Buy
3,877
+99
+3% +$11.7K 0.14% 113
2019
Q1 		$491K Sell
3,778
-181
-5% -$22K 0.17% 95
2018
Q4 		$458K Hold
3,959
– – 0.16% 87
2018
Q3 		$424K Sell
3,959
-87
-2% -$8.7K 0.15% 113
2018
Q2 		$346K Buy
4,046
+141
+4% +$11.6K 0.13% 132
2018
Q1 		$302K Buy
3,905
+64
+2% +$5.15K 0.11% 140
2017
Q4 		$324K Sell
3,841
-260
-6% -$22.1K 0.12% 133
2017
Q3 		$351K Buy
4,101
+64
+2% +$5.25K 0.14% 119
2017
Q2 		$332K Buy
4,037
+106
+3% +$8.65K 0.14% 113
2017
Q1 		$330K Buy
3,931
+370
+10% +$29.6K 0.14% 115
2016
Q4 		$262K Buy
3,561
+358
+11% +$26.7K 0.11% 134
2016
Q3 		$257K Buy
3,203
+340
+12% +$27.2K 0.12% 132
2016
Q2 		$226K Buy
2,863
+358
+14% +$27K 0.11% 138
2016
Q1 		$180K Sell
2,505
-89
-3% -$6.73K 0.09% 157
2015
Q4 		$219K Buy
2,594
+33
+1% +$2.74K 0.11% 134
2015
Q3 		$214K Sell
2,561
-1,228
-32% -$104K 0.12% 124
2015
Q2 		$317K Sell
3,789
-3,345
-47% -$255K 0.17% 115
2015
Q1 		$519K Sell
7,134
-172
-2% -$12.2K 0.28% 77
2014
Q4 		$504K Sell
7,306
-56
-0.8% -$3.78K 0.28% 77
2014
Q3 		$477K Buy
7,362
+608
+9% +$38.5K 0.29% 79
2014
Q2 		$420K Buy
6,754
+618
+10% +$36.9K 0.25% 93
2014
Q1 		$361K Sell
6,136
-375
-6% -$20.9K 0.23% 100
2013
Q4 		$332K Buy
6,511
+378
+6% +$18.9K 0.23% 102
2013
Q3 		$309K Buy
6,133
+233
+4% +$12.2K 0.24% 92
2013
Q2 		$289K Buy
+5,900
New +$321K 0.23% 98

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Parkside Financial Bank & Trust's LLY Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Eli Lilly (LLY) stake by 0.1% in Q1 2026, buying an estimated $8.11K and bringing the position to 7,749 shares worth $7.13M. The position accounts for 0.55% of the portfolio, ranked #32.

Parkside Financial Bank & Trust first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.32M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Parkside Financial Bank & Trust held 7,749 shares of Eli Lilly worth $7.13M as of Q1 2026.
  • Parkside Financial Bank & Trust bought 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
  • Eli Lilly made up 0.55% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #32 holding.
  • Parkside Financial Bank & Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Parkside Financial Bank & Trust's Eli Lilly position peaked at $8.32M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.